EBOS Group Limited ( (AU:EBO) ) just unveiled an announcement.
EBOS Group Limited has successfully completed a fully underwritten placement, raising approximately A$200 million (NZ$217 million) through the issuance of 5.9 million new shares. The funds will support the acquisition of SVS Veterinary Supplies and a full stake in Transmedic, enhancing EBOS’s market position in New Zealand’s veterinary sector and Southeast Asia’s healthcare distribution market. The placement was well-received by both existing and new investors, reflecting strong market confidence in EBOS’s growth strategy.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services including veterinary supplies and healthcare distribution. The company focuses on expanding its market presence in New Zealand and Southeast Asia, particularly in the veterinary and healthcare distribution sectors.
YTD Price Performance: 4.81%
Average Trading Volume: 47,466
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$6.8B
For an in-depth examination of EBO stock, go to TipRanks’ Stock Analysis page.